SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Raymond Duray who wrote (141)4/17/2003 2:39:17 PM
From: SBHX  Read Replies (1) of 4232
 
Smallpox, before the vaccine was developed was a relatively high mortality disease. Unfortunately, the vaccination program stopped when WHO declared it was eradicated and if it were to break out again, there would be many deaths again. But there are risks always with any vaccination and nowadays, many are all spoiled and softened by too many years of easy living to take that tiny risk. When smallpox was raging worldwide, that risk of complications from the vaccine seemed tiny.

I am reminded of stories of the spanish flu and bubonic plague of days past. The spanish flu only killed about 675,000 americans, with 200,000 deaths October 1918 alone. Eventually, everyone became immune and we all moved on. But I assume millions did die all over the world.

And yet, it is not the %age of mortality that is the problem with SARS and smallpox but how easily these diseases are transmitted. If it was like ebola, which had a much higher mortality but low transmission, then it is not that big of a problem.

However, who here hasn't caught a cold in the last 2 yrs?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext